Glass House Brands (GLAS) Non-Current Debt (2020 - 2026)

Glass House Brands' (GLAS) quarterly Non-Current Debt came in at $67.8 million in Q1 2026, up 3.07% year-on-year from $65.8 million in Q1 2025, and down 1.18% on a QoQ basis from $68.6 million in Q4 2025.

Glass House Brands (GLAS) Non-Current Debt (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Non-Current Debt data on file, last reported at $67.8 million in Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 3.07% year-over-year to $67.8 million in Q1 2026; TTM through Mar 2026 was $67.8 million, a 3.07% increase from a year earlier, with the FY2025 full-year figure at $68.6 million, up 35.76% from the prior year.
  • Non-Current Debt for Q1 2026 stood at $67.8 million, down from $68.6 million in the prior quarter.
  • Over the last five years, Non-Current Debt for GLAS reached as high as $68.8 million in Q3 2025 and fell as low as $45.1 million in Q1 2022.
  • Historically, Non-Current Debt has averaged $60.4 million across 5 years, with a median of $62.6 million in 2022.
  • Across the five-year window, Non-Current Debt surged 30048.31% in 2022 and dropped 18.27% in 2024, its largest moves.
  • Year by year, Non-Current Debt stood at $62.6 million in 2022, then decreased by 9.75% to $56.5 million in 2023, then declined by 10.55% to $50.6 million in 2024, then jumped by 35.76% to $68.6 million in 2025, then slipped by 1.18% to $67.8 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $67.8 million in Q1 2026, $68.6 million in Q4 2025, and $68.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 14.02 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 3.74 Bn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 67.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 67.82 Mn
Dec 31, 2025 68.63 Mn
Sep 30, 2025 68.81 Mn
Jun 30, 2025 65.85 Mn
Mar 31, 2025 65.80 Mn
Dec 31, 2024 50.55 Mn
Sep 30, 2024 52.20 Mn
Jun 30, 2024 53.70 Mn
Mar 31, 2024 54.88 Mn
Dec 31, 2023 56.51 Mn
Sep 30, 2023 63.87 Mn
Jun 30, 2023 63.63 Mn
Mar 31, 2023 62.89 Mn
Dec 31, 2022 62.62 Mn
Sep 30, 2022 62.41 Mn
Jun 30, 2022 61.89 Mn
Mar 31, 2022 45.07 Mn
Dec 31, 2021 44.82 Mn
Sep 30, 2021 207,000.00
Jun 30, 2021 217,000.00